SignaTalk Series Featuring New Signatera CRC Data

Dr. Angle Rodrigues and Dr. Alexey Aleshin discussed how the latest ASCO GI data can be applied to better stratify high risk patients and the emerging role of ctDNA to better monitor GI cancers.

Personalized tumor-informed test for actionable intelligence about breast cancer

Discover the Genetic Etiology of Kidney Disease with Renasight

Signatera Endpoints Webinar

Presenters: Dr. Alex Aleshin

10 Years with Anora: SNP Array Analysis of 63,000+ Products of Conception

Digital Solutions to Simplify Hereditary Cancer Testing

ACOG/SMFM Guidelines Update on NIPT Use (Practice Bulletin 226)

Support Services to Deliver Carrier Screening to Patients

Clinical Utility of Fetal Sex Accuracy

Hereditary Cancer Testing, Simplified: Integrating Risk Assessment into Routine practice

Why Carrier Screening - Perspectives from an SMA Parent

Panorama Outcomes Study with 1 Million Patients

Real-world experience with Panorama Non-Invasion prenatal testing (NIPT)

Adapting Genetic Testing Workflow to the COVID-19 Outbreak

The next innovation in NIPT technology

Why Screen for 22q11.2 Deletion Syndrome?

Panorama for Twins: Clinical Advantages of SNP-based NIPT

Overview of DMD and Patient Story

Panorama® NIPT and Sex Chromosome Screening

Importance of Fetal Fraction and Counting vs SNP NIPT